Properties
Description
Natsudaidain inhibits tumour necrosis factor-alpha and cyclooxygenase-2 production by suppressing p38 MAPK phosphorylation but not p65 NFkappaB phosphorylation, and that natsudaidain might alleviate inflammatory diseases. This product can be used for research in the fields of medicine and pharmacy.
Molecular Formula
C21H22O9
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Stability
The product is stable for two years when stored at the recommended temperature.
Applications
Natsudaidain can be used for research in the fields of medicine and pharmacy.
Storage
Store at 4°C. Protect from light.